Authors: Israel Berger, Amina Ahmad, Akhil Bansal, Tanvir Kapoor, Douglas Sipp, and John E.J. Rasko
Summary:
A structured search reveals that online marketing of stem-cell-based interventions is skewed toward developed economies including the United States, Ireland, Australia, and Germany. Websites made broad, imprecise therapeutic claims and frequently failed to detail procedures. Widespread marketing poses challenges to regulators, bioethicists, and those seeking realistic hope from therapies.
Source:
Cell Stem Cell; 2016